A novel finding of this study is that chemerin may act as a potential biomarker for the diagnosis of atherosclerosis and restenosis after percutaneous coronary intervention as well as a prospective target for therapy of the diseases. The gene discussed is RARRES2; the disease is atherosclerosis.